文(wen)章(zhang)來(lai)源(yuan):山(shan)東(dong)國資委 發布時間:2012-04-11
自(zi)2011年(nian)4月1日起(qi),魯抗醫藥(yao)(yao)公(gong)司對納入基(ji)本(ben)藥(yao)(yao)物目錄的(de)13個品種(zhong)41個規格的(de)產(chan)品實(shi)(shi)(shi)施(shi)電(dian)(dian)(dian)子監管碼制度(du),實(shi)(shi)(shi)現了(le)(le)基(ji)本(ben)藥(yao)(yao)物品種(zhong)從生(sheng)產(chan)到(dao)流(liu)通的(de)全程追(zhui)(zhui)溯(su),可有(you)效保(bao)障公(gong)眾(zhong)的(de)用(yong)藥(yao)(yao)安(an)全。電(dian)(dian)(dian)子監管碼中,對每(mei)件(jian)藥(yao)(yao)品的(de)生(sheng)產(chan)時(shi)間、銷售地點以及銷售渠(qu)道進行跟蹤(zong)記錄,為從源頭實(shi)(shi)(shi)現質(zhi)量監管建立電(dian)(dian)(dian)子檔案、對市場實(shi)(shi)(shi)現跟蹤(zong)追(zhui)(zhui)溯(su)、索證索票(piao)、實(shi)(shi)(shi)施(shi)進貨檢查驗(yan)收、建立購銷電(dian)(dian)(dian)子臺賬和缺陷產(chan)品召回提供(gong)了(le)(le)信息技術保(bao)障。因其具有(you)唯一(yi)(yi)性,猶如(ru)為每(mei)件(jian)產(chan)品配備了(le)(le)專署“電(dian)(dian)(dian)子身份證”。實(shi)(shi)(shi)行藥(yao)(yao)品電(dian)(dian)(dian)子監管,實(shi)(shi)(shi)現了(le)(le)對藥(yao)(yao)品生(sheng)產(chan)、流(liu)通和使用(yong)等環節的(de)全過程監管和追(zhui)(zhui)溯(su),一(yi)(yi)旦出(chu)現藥(yao)(yao)品不良反應和事故(gu),能夠在第(di)一(yi)(yi)時(shi)間追(zhui)(zhui)溯(su)藥(yao)(yao)品去向,控制使用(yong)。同時(shi),可以防止假劣(lie)藥(yao)(yao)品流(liu)入正規渠(qu)道,為公(gong)眾(zhong)用(yong)藥(yao)(yao)安(an)全提供(gong)了(le)(le)保(bao)障。